DK0994743T3 - Behandling af inflammatoriske lidelser i tarm eller urinblære - Google Patents

Behandling af inflammatoriske lidelser i tarm eller urinblære

Info

Publication number
DK0994743T3
DK0994743T3 DK98934310T DK98934310T DK0994743T3 DK 0994743 T3 DK0994743 T3 DK 0994743T3 DK 98934310 T DK98934310 T DK 98934310T DK 98934310 T DK98934310 T DK 98934310T DK 0994743 T3 DK0994743 T3 DK 0994743T3
Authority
DK
Denmark
Prior art keywords
inflammatory disorders
treatment
bladder
intestine
patient
Prior art date
Application number
DK98934310T
Other languages
English (en)
Inventor
Jerome Zeldis
Susan Mclaughlin
Bruce Stouch
Robert Knobler
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Application granted granted Critical
Publication of DK0994743T3 publication Critical patent/DK0994743T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
DK98934310T 1997-07-10 1998-07-08 Behandling af inflammatoriske lidelser i tarm eller urinblære DK0994743T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5210197P 1997-07-10 1997-07-10

Publications (1)

Publication Number Publication Date
DK0994743T3 true DK0994743T3 (da) 2006-10-02

Family

ID=21975478

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98934310T DK0994743T3 (da) 1997-07-10 1998-07-08 Behandling af inflammatoriske lidelser i tarm eller urinblære

Country Status (19)

Country Link
US (1) US5985914A (da)
EP (1) EP0994743B1 (da)
JP (1) JP4166432B2 (da)
KR (1) KR100541784B1 (da)
CN (1) CN1230212C (da)
AT (1) ATE327800T1 (da)
AU (1) AU752616B2 (da)
CA (1) CA2295572C (da)
DE (1) DE69834724T2 (da)
DK (1) DK0994743T3 (da)
ES (1) ES2265664T3 (da)
HK (1) HK1030891A1 (da)
HU (1) HUP0004089A2 (da)
IL (2) IL133913A0 (da)
NO (1) NO20000087L (da)
NZ (1) NZ524459A (da)
PL (1) PL196145B1 (da)
PT (1) PT994743E (da)
WO (1) WO1999002215A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4166432B2 (ja) * 1997-07-10 2008-10-15 セラコス・インコーポレイテッド 腸又は膀胱の炎症性疾病の処置
US8722422B2 (en) 1999-09-03 2014-05-13 Therakos, Inc. Uninterrupted flow pump apparatus and method
US6495366B1 (en) * 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
WO2002060376A2 (en) * 2001-01-31 2002-08-08 Tolaren Induction of tolerance by apoptotic and/or necrotic cells
US20050202098A1 (en) 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
EP1469733A4 (en) 2001-11-29 2008-07-23 Therakos Inc METHODS FOR PRETREATING A SUBJECT USING EXTRACORPOREAL PHOTOPHERESIS AND / OR APOPTOTIC CELLS
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
GB0216650D0 (en) * 2002-07-18 2002-08-28 Univ Bristol Detection of disease by analysis of emissions
AU2005311769A1 (en) * 2004-12-02 2006-06-08 Isis Pharmaceuticals, Inc. Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease
WO2007004045A2 (en) * 2005-07-05 2007-01-11 Universite De Lausanne Use of a photosensitizing agent in the treatment or prevention of an inflammation-associated disorder in the gastrointestinal tract of a mammal
BRPI0618139A2 (pt) 2005-11-02 2011-08-16 Therakos Inc método de geração de células t com atividade reguladora, composição compreendendo uma população das referidas células e uso das mesmas
MX2008014110A (es) 2006-05-02 2008-11-14 Therakos Inc Metodos y reactivos para detectar la susceptibilidad a la enfermedad del injerto versus el hospedero o mortalidad relacionada con el transplante.
EP2042179A1 (en) * 2007-09-26 2009-04-01 sanofi-aventis Novel therapeutic uses of adrenergic alpha-1 receptor antagonists
US9399093B2 (en) * 2012-01-27 2016-07-26 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
DE102013101989A1 (de) * 2013-02-28 2014-09-18 B. Braun Avitum Ag Fuzzy-Logik
BR112022010129A2 (pt) * 2019-12-20 2022-08-09 Mallinckrodt Pharmaceuticals Ireland Ltd Método para gerar células imunorreguladoras em uma amostra derivada de sangue

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196281A (en) * 1976-10-20 1980-04-01 Regents Of The University Of California Psoralens
IT1088554B (it) * 1977-11-17 1985-06-10 F I D I A Spa Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina
US4398906A (en) * 1979-12-11 1983-08-16 Frederic A. Bourke, Jr. Method for externally treating the blood
US4428744A (en) * 1979-12-11 1984-01-31 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4464166A (en) 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4612007A (en) * 1981-06-16 1986-09-16 Edelson Richard Leslie Method and system for externally treating the blood
FR2521998B1 (fr) * 1982-02-25 1985-10-25 Inst Nat Sante Rech Med Pyrido (3,4-c) psoralenes, obtention, applications en cosmetologie et a titre de medicaments et compositions cosmetiques et pharmaceutiques les contenant
FR2521999B1 (fr) * 1982-02-25 1984-05-25 Inst Nat Sante Rech Med Pyrido (3',4' : 4,5) furo (3,2-g) coumarines ou pyrido (3,4-h) psoralenes, obtention, applications en cosmetologie et a titre de medicaments, et compositions cosmetiques et pharmaceutiques les contenant
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5176921A (en) * 1983-05-02 1993-01-05 Diamond Scientific Co. Method of blood component decontamination by glucose addition
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
US4737140A (en) * 1984-10-29 1988-04-12 Mcneilab, Inc. Irradiation chamber for photoactivation patient treatment system
US4573962A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Cassette drawer assembly for photoactivation patient treatment system
US4681568A (en) * 1984-10-29 1987-07-21 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4623328A (en) * 1984-10-29 1986-11-18 Mcneilab, Inc. Pump monitor for photoactivation patient treatment system
US4596547A (en) * 1984-10-29 1986-06-24 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4573960A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Three phase irradiation treatment process
US4705498A (en) * 1984-10-29 1987-11-10 Mcneilab, Inc. Disposable temperature probe for photoactivation patient treatment system
US4687464A (en) * 1984-10-29 1987-08-18 Mcneilab, Inc. Zero insertion force socket for photoactivation patient treatment system
US4573961A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Electronic control methods for puvapheresis apparatus
US4578056A (en) * 1984-10-29 1986-03-25 Extracorporeal Medical Specialties, Inc. Patient photopheresis treatment apparatus and method
US4692138A (en) * 1984-10-29 1987-09-08 Mcneilab, Inc. Pump block for interfacing irradiation chamber to photoactivation patient treatment system
US4708715A (en) * 1984-10-29 1987-11-24 Mcneilab, Inc. Light array assembly for photoactivation patient treatment system
US4568328A (en) * 1984-10-29 1986-02-04 Extracorporeal Medical Specialties, Inc. Automated photophoresis blood portion control methods and apparatus
US4643710A (en) * 1984-10-29 1987-02-17 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
USD299953S (en) 1986-02-27 1989-02-21 Mcneilab, Inc. Control panel for a patient photophoresis treatment unit
USD298279S (en) 1986-02-27 1988-10-25 Mcneilab, Inc. Disposable patient fluid irradiation chamber
US4897789A (en) * 1986-02-27 1990-01-30 Mcneilab, Inc. Electronic device for authenticating and verifying disposable elements
USD298567S (en) 1986-02-27 1988-11-15 Mcneilab, Inc. Flexible patient fluid container
USD299531S (en) 1986-02-27 1989-01-24 Mcneilab, Inc. Patient photopheresis treatment unit
US4866282A (en) * 1986-08-26 1989-09-12 Baxter International Inc. Irradiation of blood products
US4726949A (en) * 1986-08-26 1988-02-23 Baxter Travenol Laboratories, Inc. Irradiation of blood products
US4952812A (en) * 1986-08-26 1990-08-28 Baxter International Inc. Irradiation of blood products
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4960408A (en) * 1989-01-10 1990-10-02 Klainer Albert S Treatment methods and vaccines for stimulating an immunological response against retroviruses
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US5216176A (en) * 1989-01-23 1993-06-01 Lehigh University 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
US4921473A (en) * 1989-02-02 1990-05-01 Therakos, Inc. Multicomponent fluid separation and irradiation system
US4999375A (en) * 1989-04-11 1991-03-12 Hoffmann-La Roche Inc. Psoralen reagent compositions for extracorporeal treatment of blood
US5383847A (en) * 1990-03-29 1995-01-24 Therakos, Inc. Non-specific immune system enhancement
CA2089005C (en) * 1991-06-21 1999-01-19 John Chapman Method for inactivating pathogens in a body fluid
EP0633786B1 (en) * 1992-01-27 2001-08-01 Baxter International Inc. Method of inactivation of viral, parasitic and bacterial blood contaminants
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
AU4677993A (en) * 1992-08-07 1994-03-03 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
IL105741A0 (en) * 1992-05-22 1993-09-22 Genta Inc Pharmaceutical compositions for treating cellular hyperproliferation using interleukin-1 inhibitory compounds
US5651993A (en) * 1992-11-18 1997-07-29 Yale University Specific immune system modulation
US5820872A (en) * 1992-11-18 1998-10-13 Yale University Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
BR9708468A (pt) * 1996-03-29 2000-01-04 Therakos Inc Tratamento de fotoferese de leucocitos.
JP4166432B2 (ja) * 1997-07-10 2008-10-15 セラコス・インコーポレイテッド 腸又は膀胱の炎症性疾病の処置

Also Published As

Publication number Publication date
PL338071A1 (en) 2000-09-25
CA2295572C (en) 2010-07-06
NO20000087L (no) 2000-03-09
ES2265664T3 (es) 2007-02-16
CN1230212C (zh) 2005-12-07
CN1266375A (zh) 2000-09-13
IL133913A (en) 2009-09-01
AU752616B2 (en) 2002-09-26
KR100541784B1 (ko) 2006-01-10
DE69834724D1 (de) 2006-07-06
KR20010021630A (da) 2001-03-15
EP0994743A1 (en) 2000-04-26
HUP0004089A2 (hu) 2001-04-28
IL133913A0 (en) 2001-04-30
DE69834724T2 (de) 2007-05-24
US5985914A (en) 1999-11-16
WO1999002215A1 (en) 1999-01-21
JP2001509427A (ja) 2001-07-24
PL196145B1 (pl) 2007-12-31
EP0994743A4 (en) 2001-02-14
CA2295572A1 (en) 1999-01-21
HK1030891A1 (en) 2001-05-25
ATE327800T1 (de) 2006-06-15
PT994743E (pt) 2006-08-31
JP4166432B2 (ja) 2008-10-15
NO20000087D0 (no) 2000-01-07
AU8386498A (en) 1999-02-08
NZ524459A (en) 2004-11-26
EP0994743B1 (en) 2006-05-31

Similar Documents

Publication Publication Date Title
DK0994743T3 (da) Behandling af inflammatoriske lidelser i tarm eller urinblære
BR9708468A (pt) Tratamento de fotoferese de leucocitos.
PL336788A1 (en) Probucol monoesters in treating circulatory system and inflammatory diseases
DK0880350T3 (da) Behandling af dissemineret sklerose
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
EP1327454A3 (en) Method of treatment with medical agents
DK0910428T3 (da) Fotoferesebehandling af kroniske HCV-infektioner
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE402257T1 (de) Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit
DE69716341D1 (de) Verwendung von Alkanoyl-L-Carnitinen zur Herstellung eines Arzneimittels zur Behandlung von entzündlichen Darmerkrankungen
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
RU95105874A (ru) Способ лечения острых тромбозов глубоких вен нижних конечностей
RU2000100938A (ru) Лечение воспалительных заболеваний кишечника и мочевого пузыря
RU96114051A (ru) Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией
UA28207A (uk) Спосіб лікування черепно-мозкової травми
RU97111211A (ru) Способ лечения больных с хирургическим эндотоксикозом
RU96100139A (ru) Способ лечения и профилактика заболеваний организма очищением от шлаков с помощью минеральных вод источников джил-су
RU95100165A (ru) Способ лечения прогрессирующей близорукости